Exelixis
EXEL
#1633
Rank
C$14.98 B
Marketcap
$53.55
Share price
1.24%
Change (1 day)
65.83%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: C$14.98 Billion

As of March 2025 Exelixis has a market cap of C$14.98 Billion. This makes Exelixis the world's 1633th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025C$14.98 B8.16%
2024C$13.85 B40.02%
2023C$9.89 B40.94%
2022C$7.02 B-4.75%
2021C$7.37 B-7.16%
2020C$7.93 B13.54%
2019C$6.99 B-12.98%
2018C$8.03 B-28.94%
2017C$11.30 B94.65%
2016C$5.80 B225.71%
2015C$1.78 B444.82%
2014C$0.32 B-72.81%
2013C$1.20 B44.25%
2012C$0.83 B27.85%
2011C$0.65 B-27.2%
2010C$0.89 B7.17%
2009C$0.83 B29.84%
2008C$0.64 B-28.52%
2007C$0.90 B-10.35%
2006C$1.00 B9.96%
2005C$0.91 B6.89%
2004C$0.85 B31.24%
2003C$0.65 B-13.11%
2002C$0.75 B-49.53%
2001C$1.48 B45.19%
2000C$1.02 B

End of Day market cap according to different sources

On Mar 23rd, 2025 the market cap of Exelixis was reported to be:

C$14.80 Billion
by Nasdaq info icon info icon
C$14.80 Billion
by CompaniesMarketCap info icon info icon
C$14.80 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$112.58 B 651.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$201.06 B 1,241.67%๐Ÿ‡ซ๐Ÿ‡ท France
C$332.34 B 2,117.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$176.43 B 1,077.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$241.85 B 1,513.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$562.93 B 3,656.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$211.13 B 1,308.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$31.36 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.74 B-95.02%๐Ÿ‡บ๐Ÿ‡ธ USA